CDER: Pharmaceutical Supply Chain Governance Board
The Center for Drug Evaluation and Research has created the Pharmaceutical Supply Chain Governance Board (SCGB). Slated to launch this month, the role of the board reportedly is to help facilitate and coordinate supply chain initiatives across the agency, and to offer strategic guidance on significant supply chain issues.
In a statement about the board’s creation, CDER director Patrizia Cavazzoni said, “While we remain vigilant in our response to the pandemic, it is clear that there is significant risk to the pharmaceutical supply chain from future emergencies, and consistent focus will be needed to ensure uninterrupted access to life-saving medicines.”